AU2387997A - Stabilized medicaments containing cysteinyl derivatives - Google Patents
Stabilized medicaments containing cysteinyl derivativesInfo
- Publication number
- AU2387997A AU2387997A AU23879/97A AU2387997A AU2387997A AU 2387997 A AU2387997 A AU 2387997A AU 23879/97 A AU23879/97 A AU 23879/97A AU 2387997 A AU2387997 A AU 2387997A AU 2387997 A AU2387997 A AU 2387997A
- Authority
- AU
- Australia
- Prior art keywords
- stabilized
- medicaments containing
- derivatives
- containing cysteinyl
- cysteinyl derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1997/001941 WO1998047534A1 (en) | 1997-04-18 | 1997-04-18 | Stabilized medicaments containing cysteinyl derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2387997A true AU2387997A (en) | 1998-11-13 |
Family
ID=8166591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU23879/97A Abandoned AU2387997A (en) | 1997-04-18 | 1997-04-18 | Stabilized medicaments containing cysteinyl derivatives |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0971743B1 (en) |
JP (1) | JP2001524087A (en) |
AU (1) | AU2387997A (en) |
DE (1) | DE59712694D1 (en) |
WO (1) | WO1998047534A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1051165A2 (en) | 1998-01-26 | 2000-11-15 | Mitokor | Mitochondria protecting agents for treating mitochondria associated diseases |
WO2000021507A2 (en) * | 1998-10-12 | 2000-04-20 | Andreas Bockelmann | Pharmaceutically active composition |
IT1303693B1 (en) * | 1998-11-03 | 2001-02-23 | Formenti Farmaceutici Spa | METAMIZOLE CONTROLLED RELEASE COMPOSITIONS. |
EP1150660B1 (en) * | 1999-02-11 | 2004-01-21 | Hexal Ag | Pharmaceutical effervescent formulation containing metamizol |
IT1311923B1 (en) * | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
IT1311921B1 (en) * | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
IT1311924B1 (en) * | 1999-04-13 | 2002-03-20 | Nicox Sa | PHARMACEUTICAL COMPOUNDS. |
DE19925499A1 (en) * | 1999-06-04 | 2000-12-07 | Beiersdorf Ag | Use of ascorbic acid and one or more flavone derivatives and / or flavonone derivatives, in particular flavonoids, for the preparation of cosmetic or dermatological preparations for the prophylaxis or relief of sunburn |
SE9904132D0 (en) * | 1999-11-16 | 1999-11-16 | Sbl Vaccin Ab | Pharmaceutical composition for treatment of diarrhea |
IT1318427B1 (en) * | 2000-03-27 | 2003-08-25 | A C R Applied Coating Res S A | CHEWING RUBBER CONTAINING SULFURATED AMINO ACIDS COMPOUNDS. |
ATE325612T1 (en) | 2000-07-28 | 2006-06-15 | Immupharm Aps | USE OF HYDROXYETHYL RUTOSIDES TO TREAT COLD SYMPTOMS, ALLERGIC RHINITIS SYMPTOMS AND RESPIRATORY INFECTIONS |
FR2812873B1 (en) | 2000-08-11 | 2003-08-01 | Barry Callebaut France | PROCESS FOR PRODUCING POLYPHENOLS FROM COCOA BEANS |
NZ524869A (en) * | 2000-09-22 | 2005-06-24 | Mars Uk Ltd | Food supplement |
FR2815541B1 (en) * | 2000-10-24 | 2008-02-29 | Lipha | USE OF PERICYTE APOPTOSIS INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF DIABETIC RETINOPATHY |
CA2423930C (en) * | 2000-10-27 | 2009-11-24 | Leo Pharma A/S | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
AT410895B (en) * | 2001-01-16 | 2003-08-25 | Fresenius Kabi Austria Gmbh | Storage-stable, ready-for-use infusion solution of diclofenac salt, useful for treating acute pain, also containing N-acetyl-L-cysteine, sodium ethylenediamine tetraacetic acid dihydrate and an isotonic agent |
JP4592249B2 (en) * | 2001-11-30 | 2010-12-01 | 江崎グリコ株式会社 | Food / drinks and medicines for rheumatic symptoms |
SK2822004A3 (en) * | 2001-12-18 | 2005-01-03 | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | Parenteral composition of paracetamol |
AT413794B (en) * | 2002-09-19 | 2006-06-15 | Mayrhofer Pharmazeutika Ges M | PHARMACEUTICAL PREPARATION OF DICLOFENAC SODIUM |
DE10321029A1 (en) * | 2003-05-10 | 2004-12-02 | Sigrid Heide | Medicines with selenite |
US8349359B2 (en) | 2004-11-07 | 2013-01-08 | Your Energy Systems, LLC | Liposomal formulation for oral administration of glutathione (reduced) |
EP1906930A2 (en) * | 2005-07-13 | 2008-04-09 | Al Czap | Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
JP5558712B2 (en) * | 2005-08-02 | 2014-07-23 | ドロサファーム アクチェンゲゼルシャフト | Pharmaceutical composition comprising indomethacin and / or acemetacin |
US20080213339A1 (en) * | 2005-08-02 | 2008-09-04 | Roger Imboden | Pharmaceutical Composition Containing Indometacin and/or Acemetacin |
CN100464745C (en) * | 2006-04-07 | 2009-03-04 | 山东轩竹医药科技有限公司 | Medication composition of acetyl cysteine or its pharmaceutical salt and asarin |
ATE554769T1 (en) * | 2006-12-06 | 2012-05-15 | Cornell Res Foundation Inc | MEDIUM-DURING NEUROMUSCULAR BLOCKERS AND ANTAGONISTS ADVON |
JP2008179632A (en) * | 2006-12-29 | 2008-08-07 | Fuji Chem Ind Co Ltd | Antioxidant |
US20100021511A1 (en) * | 2007-01-05 | 2010-01-28 | Fujifilm Corporation | Dispersion composition, cosmetic preparation for skin care, and method for producing dispersion composition |
GB0801119D0 (en) | 2008-01-22 | 2008-02-27 | Barry Callebaut Ag | Composition |
JP4908448B2 (en) * | 2008-03-26 | 2012-04-04 | ロート製薬株式会社 | Pharmaceutical formulation |
WO2010107488A1 (en) | 2009-03-17 | 2010-09-23 | Cornell University | Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
CN102573794B (en) * | 2009-08-19 | 2017-03-15 | 康奈尔大学 | Cysteine for physiologic infusion |
FR2972327B1 (en) * | 2011-03-11 | 2017-08-11 | Laboratoires Le Stum | MUCOADHESIVE NUTRACEUTICAL COMPOSITION COMPRISING ANTIOXIDANT ASSOCIATION |
WO2013020600A1 (en) * | 2011-08-11 | 2013-02-14 | Cross Sa | Pharmaceutical composition comprising a drug containing at least one toxicophore function and n-acetyl-l-cysteine |
ES2923651T3 (en) | 2017-02-24 | 2022-09-29 | Bioactor B V | Flavanones for use in the treatment of visceral hypersensitivity |
US20200121618A1 (en) * | 2017-04-14 | 2020-04-23 | Bioelectron Technology Corporation | Methods and compositions for treatment of inflammation and oxidative stress |
EP4272759A4 (en) * | 2021-02-08 | 2024-12-11 | Kyowa Pharma Chemical Co., Ltd. | AGENTS FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND/OR PAIN DISEASES |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3542309A1 (en) * | 1985-11-29 | 1987-06-04 | Cardona Federico Dr | Medicinal antioxidant |
US5156852A (en) * | 1989-04-20 | 1992-10-20 | La Haye Laboratories, Inc. | Composition and method for combating macular degeneration |
DE69124223T2 (en) * | 1990-02-05 | 1997-04-30 | Lifescience Corp | FOOD ADDITIVES CONTAINING VITAMINS AND MINERALS |
FR2675996B1 (en) * | 1991-04-30 | 1993-10-15 | Georges Baritiu | COMPLEX SANOGENIC DIETETIC COMPOSITIONS. |
US5977073A (en) * | 1991-06-06 | 1999-11-02 | Life Sciences' Technologies, Inc. | Nutrient composition for treatment of immune disorders |
US5629023A (en) * | 1991-12-31 | 1997-05-13 | Bland; Jeffrey S. | Medical food composition for metabolic detoxification |
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
US5389681A (en) * | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
DE29707005U1 (en) * | 1997-04-18 | 1997-06-26 | Klinge Pharma GmbH, 81673 München | Stabilized drug containing cysteinyl derivatives |
-
1997
- 1997-04-18 JP JP54476798A patent/JP2001524087A/en not_active Withdrawn
- 1997-04-18 DE DE59712694T patent/DE59712694D1/en not_active Expired - Fee Related
- 1997-04-18 AU AU23879/97A patent/AU2387997A/en not_active Abandoned
- 1997-04-18 WO PCT/EP1997/001941 patent/WO1998047534A1/en active IP Right Grant
- 1997-04-18 EP EP97919382A patent/EP0971743B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0971743B1 (en) | 2006-07-12 |
DE59712694D1 (en) | 2006-08-24 |
EP0971743A1 (en) | 2000-01-19 |
JP2001524087A (en) | 2001-11-27 |
WO1998047534A1 (en) | 1998-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2387997A (en) | Stabilized medicaments containing cysteinyl derivatives | |
AU4892897A (en) | Phospholipid drug derivatives | |
AU7595498A (en) | Medicament dispensing cell | |
AU1151099A (en) | Azaoxindole derivatives | |
AU1825899A (en) | Dota-biotin derivatives | |
AU5902998A (en) | Medicine vial dispenser | |
AU7935398A (en) | Diaminorhodamine derivatives | |
AU6117998A (en) | 3-oxadiazolylquinoxaline derivatives | |
AU3460297A (en) | Taxane derivatives and drugs containing the same | |
AU5880498A (en) | New benzolactam derivatives and medicinal compositions containing the same | |
AU5387898A (en) | Pharmaceutical agents | |
AU1409100A (en) | Drugs | |
AU8591898A (en) | Pharmaceutical compounds | |
AU6461599A (en) | Packaging for medicaments | |
AU7904998A (en) | Pharmaceutical composition containing peptichemio | |
AU7813598A (en) | Betulinol derivatives | |
AU6940998A (en) | Phospholipid drug derivatives | |
AU6422298A (en) | Pharmaceutical composition containing a phosphorylamide and an ayntibiotic | |
AU6729498A (en) | Thiazolimine derivatives | |
AU1174199A (en) | Biphenylamidine derivatives | |
AU4001297A (en) | Capsule | |
AU6119398A (en) | Phenylpropenone compounds and medicines containing the same | |
AU9344398A (en) | Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof | |
AU1800100A (en) | Medicinal preparations | |
AU4633796A (en) | Benzoxazepine derivatives, salts thereof, and drugs containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |